- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Evolving Role of ADCs in HER2-Positive Breast Cancer: Clinical Integration from Early to Metastatic Disease
EP. 1: Evolving Horizons in HER2-Positive Breast Cancer Care
Discover how advancements in HER2-positive breast cancer treatment enhance patient outcomes through personalized therapies and innovative strategies for both early and metastatic stages.
Watch
EP. 2: Key HER2+ Patient Populations Evaluated in the DESTINY-Breast Program
Explore the latest advancements in HER2-positive breast cancer treatments, highlighting the promising results of DESTINY-Breast trials for improved patient outcomes.
Watch
EP. 3: Integrating Emerging DESTINY-Breast Data Into HER2+ Treatment Strategies
Recent trials highlight T-DXd's superior efficacy and manageable toxicity in treating high-risk HER2-positive breast cancer, reshaping treatment strategies.
Watch
EP. 4: Interpreting Key Data From KATHERINE, HER2CLIMB-05, and PATINA
Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.
Watch
EP. 5: Defining Success in Metastatic Breast Cancer Trial Design
Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.
Watch
EP. 6: Personalized Selection of HER2+ Breast Cancer Therapies
Explore the latest strategies for selecting treatment regimens in HER2-positive breast cancer, focusing on safety and patient-specific factors.
Watch
EP. 7: Navigating ADC Use and Sequencing in HER2+ Breast Cancer
Explore the latest strategies for selecting treatment regimens in HER2-positive breast cancer, focusing on safety and patient-specific factors.
Watch
EP. 8: Balancing Efficacy and Safety in HER2+ Breast Cancer Trials
Experts discuss the current status of neoadjuvant ADC therapies, eligibility criteria, and future treatment pathways for high-risk patients.
Watch
EP. 9: Exploring Off-Label HER2-Targeted Therapy in Early Breast Cancer
It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help!
Watch
EP. 10: Optimizing Safety and Adherence in HER2-Targeted Therapy Through Nursing and AE Management
Explore how evolving treatment strategies and biomarkers are transforming the management of HER2-positive breast cancer in clinical practice.
Watch
